HMN Financial Inc
Change company Symbol lookup
Select an option...
HMNF HMN Financial Inc
BAM Brookfield Asset Management Inc
XOM Exxon Mobil Corp
NEWR New Relic Inc
T AT&T Inc
AICAF Air China Ltd
MMM 3M Co
JNJ Johnson & Johnson
TIP iShares TIPS Bond ETF
OCUL Ocular Therapeutix Inc
Go

Financials : Thrifts & Mortgage Finance | Small Cap Value
Company profile

HMN Financial, Inc. (HMN) is a stock savings bank holding company that owns Home Federal Savings Bank (the Bank). The Bank operates retail banking and loan production facilities in Minnesota, Iowa and Wisconsin. The Bank has two subsidiaries, Osterud Insurance Agency, Inc., which offers financial planning products and services, and HFSB Property Holdings, LLC, which acts as an intermediary for the Bank in holding and operating certain foreclosed properties. HMN's business involves attracting deposits from the general public and businesses and using such deposits to originate or purchase one- to four-family residential, commercial real estate and multi-family mortgage loans, among others. HMN invests in mortgage-backed and related securities, the United States government agency obligations and other permissible investments. HMN serves the southern Minnesota counties of Dodge, Fillmore, Freeborn, Houston, Mower, Olmsted and Winona, and portions of Steele, Goodhue and Wabasha.

Closing Price
$13.40
Day's Change
0.10 (0.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.40
Day's Low
13.40
Volume
(Heavy Day)
Volume:
2,276

10-day average volume:
2,733
2,276

Gene Therapy Market to Reach USD 35.67 Billion by 2027; Rising Prevalence of Cancer to Bolster Growth, says Fortune Business Insights(TM)

10:31 am ET August 4, 2020 (Globe Newswire) Print

The global gene therapy market is set to gain momentum from the rising incidence of different types of cancer. The field of this therapy is undergoing several technological advancements that would help in treating cancer in those patients who are at high risks of getting affected by this disease through genetic mutations. Fortune Business Insights(TM) provided this information in a new report, titled, "Gene Therapy Market Size, Share & COVID-19 Impact Analysis, By Application (Oncology, Neurology, and Others), By Vector Type (Viral and Non-viral), By Distribution Channel (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2027." The report further mentions that the market size was USD 3.61 billion in 2019 and is projected to reach USD 35.67 billion by 2027, exhibiting a CAGR of 33.6% during the forecast period.

Highlights of This Report:

-- Detailed information about the market dynamics, growth drivers, and hindrances.

-- Elaborate analysis of the company profiles and their important strategies.

-- Extensive analysis of the dominating region & segment in the market.

-- The current, estimated, and historical sizes of the global market.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/gene-therapy-market-100243

Drivers & Restraints-

Increasing Innovations & Research Activities to Boost Growth

The U.S Food and Drug Administration (FDA) stated that it is expecting to receive more than 200 applications of this therapy by the end of 2020. This showcases that the rising number of research studies and innovations in this field would affect the gene therapy market growth positively in the near future. In North America, almost 208 companies are currently operating in this market. In addition to this, the Alliance for Regenerative Medicine declared that as of 2018, approximately 259 potential drug candidates are under Phase I clinical trials across the globe.

However, the outbreak of the COVID-19 pandemic is presently impacting the field of research. According to the director of the Office of Tissues and Advanced Therapy (FDA) named Wilson Brayan, nowadays the officials are prioritizing only those drugs that are associated with coronavirus. Hence, there hasn't been a surge in the application of potential drugs for gene therapy. This factor may hamper the market growth in the forthcoming years.

The emergence of the COVID-19 pandemic is taking its toll on a wide range of industries. Owing to the increasing disruption in supply & demand chain, several companies are at a complete halt. A few of them have commenced operations by following social distancing measures, as well as by lowering workforce. Our reports would provide in-depth information about the best strategy that you can select for gaining business confidence at the moment.

To get to know more about the short-term & long-term impact of COVID-19 on this market,

please click here: https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243

Segment-

Neurology Segment to Earn High Share Fueled by High Cost of Drugs

Based on product type, the market is divided into neurology, oncology, and others. Out of these, the neurology segment earned 78.2% in terms of gene therapy market share in 2019. This growth is attributable to the increasing usage of this therapy for treating patients living with spinal muscular atrophy.

Regional Analysis-

The U.S. to Dominate Owing to Presence of Favorable Policies

In 2019, the U.S. generated USD 2.16 billion in terms of revenue. The country is expected to dominate throughout the coming years stoked by the increasing usage of advanced gene therapies for the treatment of rare conditions. Besides, the presence of favorable reimbursement policies and guidelines would also help in propelling the market growth here. As this type of treatment is not legal in several developing nations, industry giants are emphasizing on the U.S. for launching their products.

Europe, on the other hand, is anticipated to grow significantly backed by the adoption of unique treatment options. Asia Pacific is set to hold a comparatively lower share on account of the decreasing usage of gene therapy because of its expensive nature.

Competitive Landscape-

Key Players Focus on Gaining Competitive Edge by Developing New Drugs

The market houses a large number of companies that are persistently striving to bag fast-track approvals from renowned regulatory bodies. To do so, they are conducting extensive research programs and launching new drugs. Below are two of the latest industry developments:

Quick Buy - Gene Therapy Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100243

-- July 2020: GlaxoSmithKline received license from Orchard Therapeutics for its lentiviral stable cell line technology. It will be utilized for the latter's hematopoietic stem cell gene therapy.

-- June 2019: Bluebird Bio, Inc. received an approval for Zynteglo from the European Medicines Agency (EMA). It will be used to treat beta-thalassemia in patients belonging to the age group of 12 years and above.

Fortune Business Insights(TM) lists out the names of all the gene therapy providers present in the global market. They are as follows:

-- Novartis AG

-- Spark Therapeutics, Inc.

-- Biogen

-- Gilead Sciences, Inc

-- Amgen, Inc.

-- Jazz Pharmaceuticals, Inc.

-- Sarepta Therapeutics

-- GlaxoSmithKline plc

-- Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/gene-therapy-market-100243

Detailed Table of Content:

-- Introduction

    -- Research Scope

    -- Research Scope

    -- Market Segmentation

    -- Research Methodology

    -- Definitions and Assumptions

    -- Executive Summary

    -- Market Dynamics

      -- Market Drivers

      -- Market Drivers

      -- Market Restraints

      -- Market Opportunities

      -- Key Insights

        -- Overview of Regulatory Scenario

        -- Overview of Regulatory Scenario

        -- Key Product Launches/Recalls

        -- Pipeline Analysis

        -- Scientific Advancements in Gene Therapy

        -- Key Industry developments - Mergers, Acquisitions and Partnerships

        -- Patent Analysis

        -- COVID-19 Impact on Gene Therapy Market

        -- Global Gene Therapy Market Analysis, Insights and Forecast, 2016-2027

          -- Key Findings / Summary

          -- Key Findings / Summary

          -- Market Analysis, Insights and Forecast - By Application

            -- Oncology

            -- Oncology

            -- Neurology

            -- Others

            -- Market Analysis, Insights and Forecast - By Vector Type

              -- Viral

              -- Viral

              -- Non-viral

              -- Market Analysis, Insights and Forecast - By Distribution Channel

                -- Hospitals

                -- Hospitals

                -- Clinics

                -- Others

                -- Market Analysis, Insights and Forecast - By Country

                  -- U.S

                  -- U.S

                  -- Europe

                  -- Asia Pacific

                  -- Rest of World

                  TOC Continued..!!!

                  Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/gene-therapy-market-100243

                  Have a Look at Related Reports:

                  Regenerative Medicine Market Size, Share and Global Trend By By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Geography Forecast till 2026

                  Next-Generation Sequencing (NGS) Market Size, Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026

                  Point of Care (POC) Diagnostics Market Size, Share and Global Trend By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy and Fertility Testing Products, Hematology Testing Products, Others), By End User (Hospitals Bedside, Physician's Office Lab, Urgent Care & Retail Clinics, Home and Self Testing) and Geography Forecast till 2026

                  ePharmacy Market Size, Share and Global Trend By Product (Over-the-Counter Products, Prescription Medicine) and Geography forecast till 2026

                  About Us:

                  Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

                  Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

                  At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

                  Contact Us:

                  Fortune Business Insights(TM) Pvt. Ltd.

                  308, Supreme Headquarters,

                  Survey No. 36, Baner,

                  Pune-Bangalore Highway,

                  Pune - 411045, Maharashtra, India.

                  Phone:

                  US :+1 424 253 0390

                  UK : +44 2071 939123

                  APAC : +91 744 740 1245

                  Email: sales@fortunebusinessinsights.com

                  Fortune Business Insights(TM)

                  LinkedIn | Twitter | Blogs

                  Press Release: https://www.fortunebusinessinsights.com/press-release/global-gene-therapy-market-10136

                  https://ml.globenewswire.com/media/05408ba1-26b1-4fdd-8f48-1af4df373348/small/fbi-logo-tm-png.png

                  comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.